NASA and Arizona State University’s Biodesign Institute have entered a Space Act Agreement for vaccine research on the International Space Station (ISS). Under the nonreimbursable agreement, a team headed by Cheryl Nickerson, an associate professor of life sciences at the university, will continue work started on the space shuttle that takes advantage of the effects of microgravity on infectious microorganisms to produce vaccines against disease. The Arizona State group joins ...


"Arizona State Will Study Vaccines On ISS" is Premium Content. Subscribing will provide full access to this article as well as the opportunity to access:
-- Critical intelligence on the global aviation, aerospace & defense industries
-- Consolidated, comprehensive coverage of the programs and technologies shaping the industry
-- And much more…

Already registered? here.